ICC/IF analysis of HeLa cells using GTX57605 RAIDD antibody. Blue: DAPI Green: Primary antibody Dilution: 1:100
ICC/IF analysis of HeLa cells using GTX57605 RAIDD antibody. Blue: DAPI Green: Primary antibody Dilution: 1:100
RAIDD antibody [AT14G8]
GTX57605
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
ReactivityHuman
TargetCRADD
Overview
- SupplierGeneTex
- Product NameRAIDD antibody [AT14G8]
- Delivery Days Customer9
- Application Supplier NoteWB: Recommended starting dilution is 1:500.. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAT14G8
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID8738
- Target nameCRADD
- Target descriptionCASP2 and RIPK1 domain containing adaptor with death domain
- Target synonymscaspase and RIP adaptor with death domain; CRADD/LYZ fusion; death adaptor molecule RAIDD; death domain containing protein CRADD; death domain-containing protein CRADD; MRT34; RAIDD; RIP-associated ICH1/CED3-homologous protein with death domain
- HostMouse
- IsotypeIgG2a
- Protein IDP78560
- Protein NameDeath domain-containing protein CRADD
- Scientific DescriptionThis gene encodes a protein containing a death domain (DD) motif. This protein recruits caspase 2/ICH1 to the cell death signal transduction complex, which includes tumor necrosis factor receptor 1 (TNFR1A) and RIPK1/RIP kinase, and acts in promoting apoptosis. A mutation in this gene was associated with cognitive disability. A related pseudogene is found on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203